Cardiovascular disease risk assessment in Australian community pharmacy

McNamara, Kevin P., Peterson, Gregory M., Hughes, Josie, Krass, Ines, Versace, Vincent, Clark, Robyn A. and Dunbar, James 2016, Cardiovascular disease risk assessment in Australian community pharmacy, Heart, lung and circulation, In Press, pp. 1-10, doi: 10.1016/j.hlc.2016.10.016.

Attached Files
Name Description MIMEType Size Downloads

Title Cardiovascular disease risk assessment in Australian community pharmacy
Author(s) McNamara, Kevin P.ORCID iD for McNamara, Kevin P.
Peterson, Gregory M.
Hughes, Josie
Krass, Ines
Versace, VincentORCID iD for Versace, Vincent
Clark, Robyn A.
Dunbar, JamesORCID iD for Dunbar, James
Journal name Heart, lung and circulation
Season In Press
Start page 1
End page 10
Total pages 10
Publisher Elsevier
Place of publication Amsterdam, The Netherlands
Publication date 2016-11-30
ISSN 1443-9506
Keyword(s) absolute risk
community pharmacy
community screening
disease prevention
primary care
Summary BACKGROUND: Population screening and monitoring of cardiovascular risk is suboptimal in Australian primary care. The role of community pharmacy has increased considerably, but without any policy framework for development. The aim of this study was to explore the nature of community pharmacy-based screening models in Australia, capacity to increase delivery of pharmacy screening, and barriers and enablers to increasing capacity. METHODS: An online survey weblink was emailed to pharmacy managers at every quality-accredited pharmacy in Australia by the Quality Pharmacy Care Program. The 122-item survey explored the nature of screening services, pharmacy capacity to deliver services, and barriers and enablers to service delivery in considerable detail. Adaptive questioning was used extensively to reduce the participant burden. Pharmacy location details were requested to facilitate geo-coding and removal of duplicate entries. A descriptive analysis of responses was undertaken. RESULTS: There were 294 valid responses from 4890 emails, a 6% response rate. Most pharmacies (79%) had private counselling areas. Blood pressure assessment was nearly universal (96%), but other common risk factor assessments were offered by a minority. Most did not charge for assessments, and 59% indicated capacity to provide multiple risk factor assessments. Fewer than one in five (19%) reported any formal arrangements with general practice for care coordination. Financial viability was perceived as a key barrier to service expansion, amid concerns of patient willingness to pay. Support from government and non-governmental organisations for their role was seen as necessary. CONCLUSION: There appears to be a critical mass of pharmacies engaging in evidence-based and professional services. Considerable additional support appears required to optimise performance across the profession.
Language eng
DOI 10.1016/j.hlc.2016.10.016
Field of Research 110299 Cardiorespiratory Medicine and Haematology not elsewhere classified
1102 Cardiovascular Medicine And Haematology
1117 Public Health And Health Services
Socio Economic Objective 920103 Cardiovascular System and Diseases
HERDC Research category C1 Refereed article in a scholarly journal
ERA Research output type C Journal article
Copyright notice ©2016, Elsevier
Persistent URL

Document type: Journal Article
Collections: Faculty of Health
School of Medicine
Connect to link resolver
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 9 times in TR Web of Science
Scopus Citation Count Cited 8 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 462 Abstract Views, 1 File Downloads  -  Detailed Statistics
Created: Mon, 23 Jan 2017, 14:14:45 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact